Search Results

questionable. Within the past few decades, ICU outcomes have improved drastically, owing to better management techniques, early identification of sicker patients, and more lenient admission criteria for ICUs. One recent study reported a 35% relative decrease

,739 postmenopausal women with prior hysterectomy 12 ( Figure 1 ). The primary outcome monitored for benefit was coronary heart disease and the primary outcome monitored for harm was invasive breast cancer. A global index of time to first Figure 1 Women

Patient outcomes have become an integral end point as the nation’s medical training, research, and delivery system transforms into a patient-centered, value-based accreditation and reimbursement system. The components of patient-centered outcomes

Thus, elucidating the epidemiology of CDI and its impact on outcomes in patients with cancer is imperative. We used the National Hospital Discharge Survey (NHDS) database to evaluate the incidence of CDI in patients with both solid organ and

palliative care-type treatment, given that this term is perceived to cause less distress to patients, their caregivers, and clinicians. 7 , 21 Symptom control and, therefore, quality of life are the end points of supportive care, while the main outcome is

(mPhenoAge), has recently been reported, which is able to capture risk of adverse clinical outcomes across diverse tissue types 19 ; mPhenoAge has not yet been evaluated in a population with blood cancer. In this study, we explored mPhenoAge, markers of

supportive care medications can increase the potential for clinically significant drug–drug interactions and adverse outcomes. 8 Polypharmacy is also associated with an increased risk of taking potentially inappropriate medications (PIMs; medications with a

Background Patients with cancer often experience loss of skeletal muscle, which adversely impacts clinical outcomes. 1 , 2 Although most patients with cancer experience some degree of muscle loss, severe muscle loss contributes to approximately 20

palliative care consultation remains limited for patients in SNFs. 10 We sought to understand clinical outcomes of patients with stage II–IV pancreatic, colorectal, lung, and bladder cancers who discharge to an SNF compared with patients who discharge to home

-wide association studies associated with increased risk for hypogonadism. 11 No study, however, has examined the prevalence of hypogonadism in North American TCS and its relationship to adverse health outcomes (AHOs). Most TCS have had one testicle (or both